Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD151 mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the CD151 transcript that governs the stability and translation of the CD151 protein, a member of the tetraspanin superfamily [3, 6]. This region contains multiple cis-regulatory elements and binding sites for microRNAs (miRNAs), such as miR-22 and miR-637, which post-transcriptionally repress CD151 expression by inducing mRNA degradation or inhibiting translation [2, 5, 11]. CD151 itself is a key mediator of cellular processes including migration, invasion, and adhesion, primarily through its robust association with laminin-binding integrins like α3β1 and α6β4 [3, 12]. In various solid malignancies, such as breast, prostate, and lung cancers, CD151 is frequently overexpressed and correlates with advanced disease stages, metastasis, and resistance to anti-cancer therapies [6, 8, 10]. Consequently, the CD151 3' UTR is an attractive therapeutic target for RNA-based interventions, including antisense oligonucleotides (ASOs) and miRNA mimics, designed to silence CD151 and suppress its oncogenic activity [2, 7, 13]. Beyond oncology, the regulation of CD151 mRNA levels has been implicated in the therapeutic mechanisms of mood stabilizers like lithium and valproate in the treatment of bipolar disorder [1].
miRNA-mediated translational repression and mRNA degradation; antisense oligonucleotide-mediated gene silencing through RNase H recruitment or steric hindrance of regulatory elements.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD151 mRNA 3' untranslated region (CD151 3' UTR).